Friday, July 29, 2016

Pharmacologic Considerations in the Treatment of Hepatitis C Virus in Persons With HIV

An error occurred in a 15 July 2016 supplement article [MacBrayne CE and Kiser JJ. Pharmacologic Considerations in the Treatment of Hepatitis C Virus in Persons With HIV. Clin Infect Dis 2016; 63(S1):12–23]. In the second paragraph under the Velpatasvir section, the second sentence should state that the agents should be taken 4 hours before food, and not simultaneously. The online version of the article has been corrected but the print version has the original wording.
The authors apologize for this error.

No comments:

Post a Comment